tiprankstipranks
Assembly Biosciences (ASMB)
NASDAQ:ASMB

Assembly Biosciences (ASMB) Financial Statements

515 Followers

Assembly Biosciences Financial Overview

Assembly Biosciences's market cap is currently ―. The company's EPS TTM is $-10.826; its P/E ratio is -1.23; Assembly Biosciences is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-2.23. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 5.79M---$ 153.00K
Gross Profit$ 5.79M---$ 153.00K
EBIT$ -10.73M$ -15.05M$ -16.90M$ -18.95M$ -22.98M
EBITDA$ -10.70M$ -14.93M$ -16.94M$ -18.88M$ -22.93M
Net Income Common Stockholders$ -9.08M$ -14.42M$ -16.90M$ -18.95M$ -22.39M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 112.98M$ 46.21M$ 59.83M$ 73.02M$ 91.61M
Total Assets$ 119.88M$ 51.63M$ 66.58M$ 82.50M$ 101.79M
Total Debt$ 1.94M$ 919.00K$ 1.77M$ 2.63M$ 3.46M
Net Debt$ -111.04M$ -45.29M$ -58.06M$ -70.39M$ -88.14M
Total Liabilities$ 87.28M$ 9.91M$ 11.63M$ 12.78M$ 19.13M
Stockholders Equity$ 32.60M$ 41.71M$ 54.95M$ 70.33M$ 82.66M
Cash Flow-
Free Cash Flow$ -18.38M$ -13.98M$ -13.68M$ -23.43M$ -19.25M
Operating Cash Flow$ -18.36M$ -13.85M$ -13.63M$ -23.43M$ -19.25M
Investing Cash Flow$ 17.27M$ 18.88M$ -8.37M$ 10.00M$ 16.56M
Financing Cash Flow--$ 134.00K$ 4.49M$ 437.00K
Currency in USD

Assembly Biosciences Earnings and Revenue History

Assembly Biosciences Debt to Assets

Assembly Biosciences Cash Flow

Assembly Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis